Home / Generics

Generics

News

US approves generic of narcolepsy drug Xyrem posted 24/02/2017

The US Food and Drug Administration (FDA) has approved the first generic version of Xyrem (sodium oxybate) – the only drug ap...

Endo launches generic version of Zetia posted 31/01/2017

Ireland-based Endo International plc has announced that its operating company Par Pharmaceutical will ship the first generic...

Natco Pharma and Alvogen launch first US Tamiflu generic posted 20/01/2017

Natco Pharma (Natco) and their marketing partner Alvogen have launched the first generic equivalent of Roche’s flu treatment...

Mylan launches generic EpiPen posted 16/01/2017

US-based drugmaker Mylan announced on 16 December 2016 that it had launched the authorized generic version of its EpiPen (epi...

Lupin and Natco’s Armodafinil generic approved to treat sleep disorders by FDA posted 16/01/2017

The US subsidiary of Indian drug manufacturer, Lupin Pharmaceuticals, announced on 29 November 2016 that its Armodafinil tabl...

 

Research

Generics and brand-name drugs compared posted 17/02/2017

What differentiates generics from brand-name medications? That is a question that Andrea Bakker from the Faculty of Medicine...

Switching stable kidney transplant patients to generic tacrolimus safe posted 10/02/2017

Researchers from Chile have found that switching stable kidney transplant patients to generic tacrolimus is safe. However, th...

Patent and regulatory exclusivities driving generic and follow-on market availability posted 03/02/2017

Daniel Nam reviews the differences between intellectual property exclusivity (patents) and regulatory exclusivities (market e...

Addressing patient misconceptions about generics posted 02/12/2016

In the face of increasing drug costs, substitution by generics is often used as a strategy by healthcare systems to rein in e...

Policies to address price rises in old generics posted 25/11/2016

Old, off-patent drugs are becoming increasingly expensive. But how can policymakers address the problem? Naren P Tallapragada...

 

General

Novo Nordisk becomes second pharma company to cap price hikes posted 17/02/2017

Danish pharmaceutical company Novo Nordisk has pledged to limit the price rises of its drugs to single digit increases each y...

Generics regulators outline priorities to 2020 posted 31/01/2017

The International Generic Drug Regulatory Programme (IGDRP) announced on 21 December 2016 that it had released its ‘Road...

Generics applications under review by EMA – December 2016 posted 20/01/2017

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

UK competition authority accuses Actavis of overcharging NHS posted 13/01/2017

The UK’s Competition and Markets Authority (CMA) has accused Actavis of breaching competition law by increasing the price of...

Competition does not curb high drug prices posted 10/01/2017

With increasing concern over price increases for medicines a new concern being raised is that increased competition in the ph...

Generics News Research General

more

Biosimilars News Research General

more